Zobrazeno 1 - 10
of 29
pro vyhledávání: '"P Y, Holoye"'
Publikováno v:
Cancer Chemotherapy and Pharmacology. 29:145-149
Didemnin B (NSC 325,319), a cyclic depsipeptide isolated from a Caribbean tunicate, exhibits potent preclinical antitumor activity. In previous phase I studies, 3.47 mg/m2 was the maximally tolerated dose, with nausea and vomiting being the dose-limi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54cfc070de94f76da6171773c9acd5c0
https://doi.org/10.1007/bf00687325
https://doi.org/10.1007/bf00687325
Publikováno v:
Cancer. 69(1)
The potential role of paraneoplastic Cushing's syndrome (CS) was assessed on the clinical course of patients with small cell lung cancer. A retrospective comparison was done of complications and survival rates according to the presence or absence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b490f71ea567537439a8ac281a584d4c
https://pubmed.ncbi.nlm.nih.gov/1309310
https://pubmed.ncbi.nlm.nih.gov/1309310
Autor:
P. Y. Holoye
Publikováno v:
JAMA: The Journal of the American Medical Association. 237:1221-1224
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4c2f0ba9d8bb64f47639914717cc97d
https://doi.org/10.1001/jama.237.12.1221
https://doi.org/10.1001/jama.237.12.1221
Autor:
P Y, Holoye
Publikováno v:
Comprehensive therapy. 4(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2f54a232cd3b02462e345582b52df5ce
https://pubmed.ncbi.nlm.nih.gov/414876
https://pubmed.ncbi.nlm.nih.gov/414876
Publikováno v:
JAMA. 235(11)
Bleomycin sulfate pulmonary toxicity was encountered in nine of 101 patients receiving high-dose therapy for widespread testicular cancer. The pulmonary presentation was separable into two categories: (1) an early or minimal from with dyspnea on exer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::de661ab890dd45d89ba4a9af195b9790
https://pubmed.ncbi.nlm.nih.gov/55502
https://pubmed.ncbi.nlm.nih.gov/55502
Publikováno v:
Journal of clinical pharmacology. 18(7)
A series of studies were carried out to investigate the pharmacokinetics of the antineoplastic antibiotic bleomycin in patients with neoplastic disorders. Drug was administered by long (four to five days) and short (10 minutes) zero-order infusions,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::996ed33cb7a4357c6e33180f43d10a04
https://pubmed.ncbi.nlm.nih.gov/78932
https://pubmed.ncbi.nlm.nih.gov/78932
Publikováno v:
Cancer treatment reports. 61(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5e169a75b656d8615343ae2259489c1d
https://pubmed.ncbi.nlm.nih.gov/324624
https://pubmed.ncbi.nlm.nih.gov/324624
Publikováno v:
Cancer. 36(2)
Eighty-three patients with Stage II or Stage III germinal neoplasia of the testis and 7 patients with extragonadal primary tumors were treated with bleomycin plus vinblastine, or a five-drug program, bleomycin plus cyclophosphamide, vincristine, meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f4e25c2741ea44de37cd923657be65e1
https://pubmed.ncbi.nlm.nih.gov/50869
https://pubmed.ncbi.nlm.nih.gov/50869
Publikováno v:
Cancer. 40(6)
The clinical pharmacology of bleomycin administered by continuous intravenous infusion over a 4 to 5 day period was examined by nine patients. Patients receiving 30 units per day attained an average steady state plasma level of 145.8 (+/- 43.1) ng/ml
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3e02ca1810f38a683e85652f8a4467ef
https://pubmed.ncbi.nlm.nih.gov/73408
https://pubmed.ncbi.nlm.nih.gov/73408
Publikováno v:
Seminars in oncology. 9(4 Suppl 1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::83fbf810f96f44e0bfb61c75298db2c1
https://pubmed.ncbi.nlm.nih.gov/6298946
https://pubmed.ncbi.nlm.nih.gov/6298946